Home
Conditions
Digestive System Neoplasms

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,384 public trials 3,278 recruiting studies

Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, not recruiting

Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

NCT07374003

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Sub-i Guangdong, GUANGZHOU, China

View Trial Details

Active, not recruiting

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

NCT04005339

Conditions: Advanced Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations: Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States

Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States

Washington University School of Medicine- Siteman Cancer Center St Louis, Missouri, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Active, not recruiting

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

NCT04137107

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 793 locations

View Trial Details

Active, not recruiting

A Study of SH006 Injection Combination Therapy in Patients With Advanced Solid Tumors

NCT07362264

Conditions: Digestive System Diseases, Digestive System Neoplasms, Liver Cancer, +4 more
Locations: Nanjing Tianyinshan Hospital Nanjing, Jiangsu, China

View Trial Details

Active, not recruiting

A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

NCT05708599

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations: Universitätsklinikum Schleswig-Holstein, Campus Kiel Kiel, Germany

View Trial Details

Active, not recruiting

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

NCT04767984

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +14 more
Locations: Northwestern University Chicago, Illinois, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Kansas Cancer Center Kansas City, Kansas, United States

View Trial Details

Active, not recruiting

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

NCT04377932

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, not recruiting

AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer

NCT06591520

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Harbin Medical University Cancer Hospital Harbin, China

Zhongshan Hospital, Fudan University Shanghai, China

View Trial Details

Active, not recruiting

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

NCT05198609

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Cancer Center Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study

NCT05327452

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Digestive System Neoplasms

Digestive System Neoplasms trial results

Related conditions